Amyloid-ß deposition is one of the hallmarks of Alzheimer’s disease (AD) that starts to progress decades before the onset of cognitive impairment. With the rise of the new diagnostic criteria of AD that considers the neuropathological changes as the main aspects for explaining the extent of the disease regardless the cognitive status of the patient & further highlighted the importance of finding reliable in-vivo biological markers to identify those in the preclinical stage of AD. Through the use of the transgenic mice models, particularly APPswe/PS1dE9 we could study the different pathomechanics contributing to the development of AD. So, in this study, we assumed an approach combining morphometry based on high-resolution MRI as a
This abstract and the presentation materials are available to members only; a login is required.